Clinical Trial Update: Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2a study of PRV-6527 in moderately to severely active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PRV-6527

Snippet

Sponsor: Provention Bio, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED